PRGO Q2 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+6.4% YoY

Gross Profit

$428M35.9% margin

Operating Income

$57M4.8% margin

Net Income

$8M0.7% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+1.0%

Cash Flow

Operating Cash Flow

$53M

Free Cash Flow

$33M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$6.1B

Stockholders' Equity

$4.8B

Cash & Equivalents

$555M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+6.4%
Gross Profit	$428M	$372M	+15.0%
Operating Income	$57M	-$7M	+923.2%
Net Income	$8M	-$65M	+112.9%

Revenue Segments

Consumer Self-Care Americas

$751M63%

Consumer Self-Care International

$442M37%

Geographic Segments

UNITED STATES

$736M61%

Europe

$426M35%

Other Geographical Areas

$32M3%

IRELAND

$12M1%